-+ 0.00%
-+ 0.00%
-+ 0.00%

ERASCA INC: PHASE 1 MONOTHERAPY DATA FOR ERAS-0015 & ERAS-4001 EXPECTED IN 2026

Reuters·05/13/2025 12:07:40

Please log in to view news